EP Patent

EP4671371A1 — Double-stranded sirna analogues with R and E and conjugates thereof

Assigned to YaoPharma Co Ltd · Expires 2025-12-31 · 0y expired

What this patent protects

Provided are a series of double-stranded siRNA analogs comprising R and/or E, conjugates thereof, salts of the conjugates, and uses.

USPTO Abstract

Provided are a series of double-stranded siRNA analogs comprising R and/or E, conjugates thereof, salts of the conjugates, and uses.

Drugs covered by this patent

eplontersen-sodium (EPLONTERSEN SODIUM)

Patent Metadata

Patent number: EP4671371A1
Jurisdiction: EP
Classification: —
Expires: 2025-12-31
Drug substance claim: No
Drug product claim: No
Assignee: YaoPharma Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.